Forrest Innovations Aims to Use RNAi to Combat Citrus Disease, Control Mosquitos | GenomeWeb

NEW YORK (GenomeWeb) – One of the co-founders of Beeologics — a developer of RNAi treatments for key bee disorders that was acquired in 2011 by Monsanto — has created a new business focused on using the gene-silencing technology to tackle a major threat to citrus crops and mosquito-borne diseases.

Called Forrest Innovations, the company was established by Nitzan Paldi, who in 2007 co-founded Beeologics to use RNAi to combat Israeli acute paralysis virus, a bee disease linked to colony collapse disorder, and the honey bee parasite Varroa destructor.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.